AVO vs LUNG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 16, 2026

AVO

48.0
AI Score
VS
LUNG Wins

LUNG

58.8
AI Score

Investment Advisor Scores

AVO

48score
Recommendation
HOLD

LUNG

59score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AVO LUNG Winner
Revenue 1.02B 43.34M AVO
Net Income -14.40M -23.73M AVO
Gross Margin 9.5% 78.0% LUNG
Net Margin -1.4% -54.8% AVO
Operating Income -4.00M -22.01M AVO
ROE -1.9% -60.6% AVO
ROA -0.9% -20.7% AVO
Total Assets 1.61B 114.73M AVO
Cash 47.10M 55.84M LUNG
Debt/Equity 0.52 0.96 AVO
Current Ratio 1.92 4.32 LUNG
Free Cash Flow -57.90M -15.32M LUNG

Relative Price Performance (Last 90 Days)

AVO 1M: +1.0% · 3M: -2.9% LUNG 1M: -19.3% · 3M: +24.3%

Current Technical Phase

AVO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.7 · Price: $12.90

LUNG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 40.5 · Price: $1.84

Fundamentals Snapshot

Metric AVO LUNG
Market Cap — —
Forward P/E 16.4 -2.0
Trailing P/E 437.0 —
Revenue (TTM) — —
Revenue Growth 0.3% 0.0%
Gross Margin 0.1% 0.8%
Operating Margin 0.0% -0.4%
EPS 0.03 -1.15
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, LUNG is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.